MRLlpr mice develop spontaneous systemic autoimmunity with many hallmarks of the human disease systemic lupus erythematosus. Although a variety of genes have been implicated in this model, disease pathogenesis is still poorly understood. In an effort to identify novel genes and pathways, we performed genome-wide mRNA expression analysis in the spleens and kidneys of MRLlpr mice throughout the disease course. Samples were collected from cohorts of C57BL/6, MRL þ / þ and MRLlpr mice, and profiled by flow cytometry and gene expression microarrays. Serum autoantibodies and renal pathology were studied in parallel. We identified 236 genes in MRLlpr spleen that showed significant threefold or greater changes in expression between 6 and 20 weeks. Of interest, a number of interferon-responsive genes were expressed early, and remained dysregulated throughout the disease course. Many chemokines, cell surface proteins, transcription factors and cytokines, including IFN-gamma, also showed altered expression as disease progressed. Analysis of kidneys indicated the presence of severe inflammation that coincided with evidence for changes in kidney function and elevated expression of IFNinducible genes, complement components and antigen presentation genes. These data provide a unique genomic view of the progression to fatal autoimmunity in MRLlpr mice, and provide new candidate genes and pathways to explore.
Introduction
Systemic lupus erythematosus (SLE) is a serious autoimmune disorder characterized by widespread loss of immune tolerance to self-antigens. SLE in humans leads to inflammation of many organ systems, including skin, pleural cavities, heart, kidneys, various blood elements and the brain. Recent evidence in mice suggests that the pathophysiology of lupus may involve overproduction or impaired clearance of chromatincontaining immune complexes, leading to B-cell and dendritic cell activation.
1,2 Many patients with severe SLE affecting the hematopoetic system, kidney and brain show a prominent IFN gene expression signature in peripheral blood cells, [3] [4] [5] suggesting that activation of the IFN pathway may be important for disease pathogenesis. IFN-alpha can also be induced by chromatin-containing immune complexes. 6 Autoantibodies against nuclear antigens are found in virtually all patients with SLE, and these antibodies show evidence for somatic hypermutation, indicating the involvement of CD4 T cells. Lupus is also characterized by widespread dysregulation of CD8 T cells and myeloid lineage cells, [7] [8] [9] and knockout mice for a variety of immune system genes, including many involved in negative regulation of lymphoid signaling, develop lupus-like disease. 10, 11 The MRLlpr mouse strain is one of the best-studied models for spontaneous lupus. The lpr mutation arose as a spontaneous mutation on the MRL genetic background, and was found to be a null allele for Fas (CD95), a member of the TNF family of receptors that signals for death in the immune system. 12 MRL þ / þ mice develop autoimmunity with many of the features of lupus observed in humans including a similar autoantibody profile and glomerulonephritis. The lpr mutation accelerates the autoimmune predisposition of MRL mice. The development of disease in MRLlpr mice is quite predictable. Mice exhibit serum autoantibodies at 6 weeks of age, and show palpable lymphadenopathy at 12 weeks due to the accumulation of a large and unusual population of B220 þ CD4 neg CD8 neg (double negative, DN) T cells. Mice then develop progressive renal disease and heavy proteinuria at B16 weeks, and show 50% mortality at 20 weeks. The remaining animals generally die before 28 weeks of age. 13 Genetic mapping approaches have identified a large number of susceptibility loci in human SLE and in lupusprone mice, including the MRLlpr model. 10 However, it has thus far proved challenging to isolate the responsible genes. Breeding of various transgenic and knockout alleles onto the MRLlpr background has successfully identified genes that modify disease course. 13 These include B7.1, 14 B7.2, 15 Fyn, 16 IL-12, 17 IFN-gamma, 18 and complement C3. 19 We set out to visualize disease pathogenesis in MRLlpr mice at the genomic level, by performing gene expression profiling of spleens and kidneys throughout the lifespan of the mice. Notably, we identified a prominent IFN-gamma gene expression signature in both spleen and kidney, with elevated levels of mRNA for IFNgamma in spleen and kidneys, while the type I IFNs showed minimal changes. Many additional genes and pathways were also found to be dysregulated during the evolution of disease, underscoring the complexity of systemic autoimmunity in this model.
Results

Clinical features of autoimmunity in MRLlpr mice
We followed cohorts of MRLlpr (MRLlpr) mice, together with control MRL þ / þ and C57BL/6 (B6) mice, at intervals following weaning. At each time point, spleens were harvested and the cellular composition was documented by flow cytometry. In addition, serum was obtained for measurement of autoantibodies, kidneys were harvested for histopathology, and urine was tested for proteinuria. All mice were studied as a single, longitudinal cohort.
The clinical evolution of disease in these mice was as previously described. 13 Serum anti-double-stranded DNA (dsDNA) titers increased rapidly in lpr mice between 6 and 16 weeks, and remained elevated thereafter ( Figure 1a ). Control MRL þ / þ animals also showed elevated serum anti-dsDNA autoantibody production, but only in older mice. lpr animals also showed a dramatic expansion of total splenocyte counts early on in the disease course (Figure 1b) . B cells as a percentage of splenocytes dropped significantly over time, while total B-cell numbers in spleen held relatively steady after the expansion at 8 weeks of age (Figure 1c ).
Both MRL þ / þ and lpr mice had higher percentages of mature splenic B cells carrying a marginal zone (MZ) phenotype (CD23   lo   CD21 hi ) than B6 mice. These strains also showed a progressive accumulation of effector/ memory T cells over time (CD44 hi ), along with decreased percentages of naïve T cells (Figure 1d ). There was a minor decrease in the size of the 'non-T, non-B' cell population, which include macrophages, granulocytes, natural killer cells and dendritic cells (Figure 1e ). Finally, lpr animals showed the characteristic expansion of double-negative T cells (Figure 1f ).
Normalization of tissue-specific genes
The accumulation in spleen of large numbers of doublenegative (DN) T cells in the MRLlpr model leads to major shifts in cell populations (as a percentage of total spleen cells - Figure 1) , which has the potential to complicate interpretation of the microarray results. For instance, in early analyses, we found significant decreases in the relative expression signals for a number of B-cell-specific genes, which reflected a decreased percentage of B cells in the spleens due to the accumulation of DN T cells, rather than shifts in the overall numbers of B cells. Thus, we were interested in developing an approach to lessen the complexity of these data by eliminating transcripts, such as many of the B-cell transcripts, which were changing because of the dynamic fluxes in overall cell populations in spleen.
In order to attempt to 'normalize' some of the gene expression signals, we first determined the cell-typespecific genes expressed in each of the major populations of splenic cells in MRLlpr mice, including B cells, naïve T  cells, activated T cells, memory T cells, DN T cells and  non-T non-B cells (NK, dendritic cells, and macrophages) . Each of these cell populations was sorted to high purity (495%) from two or three mice, and gene profiles were analyzed by Affymetrix GeneChips. We arbitrarily defined 'cell-type-specific' genes to be those where a particular cell type had X5-fold increased or decreased levels of expression compared with all the other major cell types, a mean 4200 expression unit difference, and P-value for the difference o0.05. These filtering criteria required an average difference of 4200 expression units, thus there was minimal bias observed for genes expressed at low levels.
A total of 221 genes met those criteria, and are shown in Figure 2a . Yellow represents genes expressed at higher levels than the pooled average of all cell populations, while blue represents genes expressed at lower levels than the mean. Each column represents an individual sorted sample.
To normalize the gene expression results for the variability of cell composition across different samples, we used the following formula for those genes determined to be cell type specific.
where Signal ik denotes the original expression level of gene i in sample k; % ctrl is the percentage of the cells in the control sample, and % sample k is the percentage in the experimental sample. A hypothetical example of this normalization is shown for a tissue-specific gene X expressed in B cells:
Thus, in this example, the original differences in gene expression values for the three samples are equalized after normalization of sample values. As an example, CD19 (B-cell specific) gene expression levels by microarray showed a decrease in MRLlpr mice over time (Figure 2d) . However, the surface CD19 expression levels on B220-gated B cells were identical between 6-and 16-week MRLlpr mice (Figure 2b ). After normalization, CD19 levels were no longer significantly different in the various samples (Figure 2e ). This normalization protocol eliminated 58 genes from the final gene list (see below). The method used for normalization affects a relatively small number of the transcripts examined, and we believe that it serves to reduce the complexity of the data set, and facilitates interpretation of the remaining differentially expressed transcripts. The raw non-normalized data are available for analyses without these statistical adjustments. and these expression patterns were compared with MRL þ / þ splenic profiles at 6, 12 or 16 weeks. Three or four spleen samples were collected at each time point and processed independently as biological replicates. We identified genes that were differentially expressed in MRLlpr mice over the course of disease using the following criteria: X3-fold difference in gene expression level between any two time points, Po0.01 for the twoway comparison, and average signal difference of 4200 expression units. All data analyses were performed on the normalized data (see above). A largely overlapping gene list was also generated using ANOVA (data not shown).
There were 236 genes differentially expressed between MRL þ / þ and MRLlpr spleen (see Figure S1 and Table S2 for details). Twenty-three of these were restricted in expression to DN T cells, while an additional 20 were restricted in expression to other cell types. Thus, while DN T-cell-enriched genes contribute significantly to the overall gene expression signatures observed in MRLlpr mice, many other genes that show large changes in expression are highly expressed in other cell populations (e.g. activated T cells, B cells, non-B/non-T populations). Furthermore, these cell-type-specific genes were only a small fraction of the total number of differentially expressed genes. We conclude that cell-specific transcripts Table S2 Most of these IFN-regulated genes showed altered levels of expression at the earliest time point sampled in lpr mice (6 weeks), and generally showed significant dysregulation only at late time points in MRL þ / þ mice. The pro-inflammatory chemokines CXCL9 and CXCL10 are known to promote Th1 responses and were expressed at high levels at early time points in lpr mice. 20, 21 IFI202, previously implicated as a lupus susceptibility gene in NZB mice, 22 was also overexpressed in lpr spleens. The elevated levels of Fas ligand (TNFSF6) is likely compensatory due to the absence of a functional Fas receptor. The levels of IFN-gamma transcripts in spleen progressively increased over time in lpr mice (Figure 4 ), while IFN-alpha and IFN-beta transcripts remained stable (not shown). The expression of many IFN-responsive genes in the spleen samples mirrored the expression pattern of IFN-gamma. Thus, these data suggest that IFN-gamma is driving the IFN signature observed.
Additional dysregulated genes in MRLlpr spleens
Many additional cytokines and chemokines, related receptors, and downstream signaling molecules also showed dysregulated expression in MRLlpr spleens (Figure 3b ). Notable were elevated levels of the proinflammatory chemokines CCL4 and CCL5, interleukin 10, granzyme K, and granzyme B, and diminished levels of interleukin 12A, lymphotoxin, and granzyme A. Two phosphatases were upregulated (PTPN13 and INPP1), while PTPRM was downregulated. Protein kinase C theta (PKC theta) showed elevated expression, and protein kinase C beta (PKC beta) showed reduced expression. Many genes involved in G-protein signaling, as well as several receptor tyrosine kinases and adaptor proteins were also dysregulated. Most of these genes showed little change in MRL þ / þ spleens until late in their lifespan, if at all.
The expression data for isotype switched Ig transcripts (IgG2b, IgG3, IgG1) ( Figure 3c ) were consistent with a prominent role for plasma cells and antibody production in disease pathogenesis in MRLlpr mice. 13 The switched
Ig transcripts also appeared early on in MRL þ / þ mice. A number of cell surface markers involved in immune regulation, including the prolactin receptor (PRLR), CD84, CRTAM, CD28, TNFRSF9 (4-1BB), and CD152 were upregulated in lpr spleen (Figure 3d ). [23] [24] [25] Notable downregulated genes included CD8 alpha chain, KLRG1, CD83, CDD7, CD160, CD37 and FCER2A, the low-affinity Fc receptor for Ig. Of the upregulated surface proteins, only CD84 showed large expression changes in MRL þ / þ mice.
Interestingly, most of the dysregulated transcription factors showed lower levels of expression in lpr mice as compared to MRL þ / þ (Figure 3e ). The downregulation of many of these genes was especially significant after the 12 weeks time point. The most prominently upregulated transcription factors were MGLAP (TEL), AKAP1, MAD3, Sox18, and SMYD1. Overall, these data are consistent with the hypothesis that de-repression of genes may be an important feature of cell activation and autoimmunity. 26 We confirmed the expression data for a number of these genes by real-time PCR and by flow cytometry (see supplementary materials).
Identifying the earliest changes in gene expression in MRLlpr mice
We next identified the transcripts that showed differences in expression between MRL þ / þ and MRLlpr spleens at the earliest time point sampled (6 weeks), since these could be 'primary' rather than 'secondary' genes influencing the progression of autoimmunity. Excluding Ig transcripts, 15 genes met the filtering criteria (Table 1 ). The only genes downregulated were the heat shock proteins HSPA1A and HSP70K. Four of the 13 upregulated genes were IFN-regulated (CXCL9, IIGP, LAG3 and HSPA1A). Another overexpressed gene was CD84, which is a member of the SLAM/CD2 family. 27 It was the only cell surface protein that was highly overexpressed in young MRLlpr mice. There is extensive genetic variation, both in coding and noncoding regions, within the SLAM gene cluster, and recent work has shown association of this cluster of genes with susceptibility to lupus in NZM2410 congenic animals (Sle1). 28 Only one transcription factor, SOX18, showed an early upregulation in expression. SOX18 is known to control the transcription of the cell adhesion molecule VCAM, 29 and is expressed in vascular endothelium and hair follicles, common targets for disease in human lupus. 
Genes dysregulated in MRL þ / þ spleen We next identified the genes that showed the largest changes in expression in MRL þ / þ spleens over time. We compared MRL þ / þ splenic expression profiles at 12, 16, 24, 36 and 60 weeks to gene levels of 6-week-old MRL þ / þ mice. Excluding immunoglobulin genes, 57 transcripts were identified (see supplementary materials). Among these genes, only one was IFN-regulated, and overall 23/57 (40.4%) were shared with the MRLlpr gene list. These data provide some support for the longheld notion that the lpr mutation accelerates the underlying autoimmune phenotype of MRL þ / þ mice, and 
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we speculate that the acceleration of disease by the lpr mutation may involve early dysregulation of the gamma IFN pathway.
Potential lupus susceptibility genes in MRLlpr mice
Genetic mapping studies have identified a number of lupus susceptibility loci in MRL þ / þ and MRLlpr mice. 31 Four of the genes from the list of 236 have previously been implicated as lupus susceptibility genes: TNFSF6 (FasL), 12 IFI202, 22 lymphotoxin A 32 and H2-D 33 ) ( Table 2 ). Another seven genes are located within 1 cM of a reported susceptibility locus, and are thus new candidate genes for these loci (Table 3) .
Genomic analysis of nephritis in MRLlpr mice
Anti-glomerular antigen (Anti-GBM) autoantibody titers increased rapidly between 6 and 16 weeks in MRLlpr mice, and remained elevated thereafter (Figure 5a ). C57BL/6 mice showed no detectable anti-GBM titers, while aged 60 weeks MRL þ / þ mice had levels comparable to 16-24 weeks MRLlpr mice. Progressive kidney disease was documented in the MRLlpr mice over time (Figure 5b and d) , and by 16 weeks of age, all MRL lpr mice had heavy proteinuria (Figure 5c ).
Whole kidney samples from 6, 12, 16 and 20 weeks old MRL lpr mice as well as 12 weeks MRL þ / þ mice were examined by microarrays, and 126 genes were identified as differentially expressed. A cluster of 19 IFN-responsive genes was highly expressed in the kidneys of lpr mice beginning at week 12 ( Figure 6a ). This coincided with elevated expression levels of Class II MHC and other genes involved in antigen presentation (Figure 6b) , several complement components including three subunits of C1q (Figure 6c ), together with several cytokines and chemokines (including CCL9 and lymphotoxin B). High levels of IgM and switched Ig transcripts, together with several T-cell-specific genes, signaled the presence of lymphocytes in kidney. The polycomb family transcription factor EZH1 was highly expressed in lpr kidneys. This family of proteins is known to be involved in repressing gene transcription by recruiting histone deacetylases to chromatin. 34 Little is known about the target genes for EZH1.
Taken together, the data suggest that the kidneys of lpr mice harbor an intense inflammatory infiltrate, with evidence that IFN, immunoglobulins, complement and chemokines are involved in mediating the inflammation that leads to parenchymal kidney damage and ultimately renal failure. Only nine genes were shared between the kidney and spleen gene lists (Table 4) , and five of these were IFN regulated, again highlighting the role of IFNgamma in driving disease pathogenesis. Similar to spleen, IFN-gamma was overexpressed in lpr kidneys at several of the time points analyzed (Figure 4 ). There were also small, but statistically significant, decreases in IFN-beta at week 12 (not shown), which is interesting given the protective role that type I IFN may have in the MRLlpr model. 35 
Discussion
We surveyed gene expression in the spleens and kidneys of MRLlpr mice in order to better understand at the genomic level the mechanisms contributing to systemic lupus-like autoimmunity. This approach identified multiple pathways and hundreds of genes that showed significant changes during disease progression. Despite the complexity, several gene 'signatures' (e.g. IFN, cytokines/chemokines and antigen processing) were identified that support existing and emerging ideas about the pathogenesis of systemic autoimmunity. In addition, we identified many genes and signatures not previously associated with systemic autoimmunity. Figure 6 Gene expression in kidneys of MRL þ / þ and MRLlpr mice. We identified the genes that best discriminated MRL þ / þ 12 weeks and MRLlpr 6, 12, 16, and 20 weeks old kidney samples using the following filtering criteria: X3-fold difference in gene expression level between any two time points, Po0.05 and average signal difference of 4200 expression units. A total of 126 genes were identified (see Table S4 for full list), and shown are genes from selected pathways and clusters. Each column represents an independent kidney sample. (a) IFN regulated genes, (b) antigen presentation genes, (c) complement genes, (d) cytokines, chemokines and signaling pathway genes, (e) immunoglobulins, (f) cell surface markers and (g) transcription factors. IFI202 is a transcription factor that influences proliferation, survival, and differentiation of B cells, 36 and is expressed at high levels in NZB mice due to promoter region polymorphisms. 22 Early studies showed that systemic administration of IFN-alpha/beta could accelerate lupus in NZB and NZB/W mice, 37, 38 and deletion of the type I IFN receptor in NZB animals resulted in reduced autoantibody production and mortality. 39 Furthermore, activation of type I IFN in C57BL/6 lpr mice resulted in increased severity of renal disease and elevated autoantibody titers, while C57BL/6 Â 129 mice deficient for both Fas and the type I IFN receptor showed reduced lymphadenopathy and immune complex deposition in the kidney. 40 While many of these previous studies implicate type I IFN in certain lupus mice, it is interesting that a knockout of IFN-gamma in MRLlpr mice delayed both the onset of disease and the severity of glomerulonephritis.
18,41 A recent study by Hron and Peng 35 addressed the issue of IFN dependence of the MRLlpr model by breeding the mice onto knockouts for the IFN-alpha/beta receptor or the IFN-gamma receptor, or generating double knockouts. Interestingly, disease in MRLlpr mice was reduced in the IFN-gamma receptor knockouts, and enhanced in IFN-alpha/beta receptor knockouts. 35 Together with our data showing the strong IFN-inducible gene signatures and the overexpression of IFN-gamma but not type I IFNs, these data suggest an important role for IFNgamma in the lpr model.
The available evidence also points to an important role for IFN in human lupus. Elevated levels of serum IFNalpha are found in some patients, [42] [43] [44] and are present at sufficient levels in SLE to induce the maturation of normal monocytes into activated DCs. 45 Patients who received IFN-alpha as a therapeutic agent for viral hepatitis or carcinoid tumors showed a high incidence of positive blood tests for antinuclear antibodies (22%), 46 and one in five (19%) developed an autoimmune disease, including a few who developed SLE (0.7%). 47 The serum of lupus patients contains an IFN-inducing factor (IIF), later identified as DNA/chromatin containing immune complexes, which can stimulate leukocytes from normal donors to produce large quantities of IFN-alpha. 48, 49 Finally, gene array experiments in peripheral blood of lupus patients have identified a prominent type I IFN signature that is associated with disease activity and more severe manifestations of SLE. [3] [4] [5] Precisely how type I IFN might initiate and then maintain phases of human lupus remains unclear, but is clearly an important question for future studies.
These data also identified dysregulated levels of transcripts for many cytokines and chemokines, together with genes from downstream signaling pathways, in MRLlpr mice, particularly at late disease stages. Elevated levels of cytokines and chemokines have long been documented in lupus, 50, 51 and likely have a role in activating dendritic cells and other cell types, driving the autoimmune process. 52, 53 Two of the chemokines identified, CXCL9 and CXCL10, are known to be IFNresponsive, and thus may relate to the underlying dysregulation of IFN-gamma production in this model. Another striking finding of these studies is the local mRNA expression of both complement genes and immunoglobulins in the kidney ( Figure 6 ). Complement gene expression is evident at 12 weeks of age in MRLlpr mice, and coincides with the initiation of clinical renal disease. While there are data to suggest that C4 and C1q deficiency may predispose to lupus-like disease in both humans and mice, 54, 55 it is unclear whether this local production of complement is a protective response to ongoing immune complex deposition, or whether it actually accelerates disease. Further studies are warranted to address this.
In summary, this report describes the application of microarray technology to study gene expression changes that accompany the evolution of lupus in the MRLlpr mouse model. These data suggest an important role for IFN-gamma in disease pathogenesis, and identify many additional genes in inflammatory pathways that are dysregulated as autoimmunity develops. As with many expression-array-based studies, our ability to fully interpret these data is currently limited, due, in part, to our lack of knowledge regarding the function of many of these genes, together with an incomplete understanding of the gene networks and interactions in this complex in vivo model for autoimmunity. An important advantage of the current approach is that there are no a priori biases about which genes or networks might be most important in the model. By identifying potentially interesting candidate susceptibility genes, and documenting the expression of thousands of genes during disease progression in these inbred mouse strains, we believe that the current study provides an important new resource for the community, and will generate a number of new and testable hypotheses for future work. ELISAs for anti-DNA and anti-GBM antibodies Anti-DNA autoantibody titers were measured as previously described. 57 Briefly, 96-well ELISA plates were coated with 5 mg/ml double-stranded calf thymus DNA (Sigma) in sodium salt citrate buffer at 371C overnight. After washing with PBS-T, sera were added in serial dilutions starting at 1/100 and incubated for 45 min. Then, after another washing with PBS-T, HRP-conjugated goat anti-mouse IgG antibody (Sigma) was added. TMB was loaded last for color development, and measured at A380. Results are reported as the absorbance at 380 nm with a 1/100 dilution. Anti-glomerular basement membrane (GBM) antibody titers were measured by ELISA in a similar fashion (Bernstein et al. 58 and wells were coated with 50 ml/well rat GBM.
Materials and methods
Mice
Flow cytometry and cell sorting Splenocytes were stained in FACS buffer (PBS, 2.5% FBS, 0.2% sodium azide) with either FITC-, PE-, CYC-, APCor biotin-conjugated monoclonal antibodies to CD3, CD4, CD8, CD62L, CD44, CD45/B220, CD19, IgM, CD21, CD23, CD11b, CD11c, CD49, and Gr-1 (BD Pharmingen, San Diego, CA, USA) for surface phenotyping. For cell sorting, cells were stained with corresponding antibodies for each population in staining buffer (1 Â PBS, 10% FBS) and sorted by FACSVantage (Becton Dickinson, Mountain View, CA, USA). The following stains were used for sorting: follicular B cells -B220 
B220
neg The purity for each cell population was X95%. Flow cytometry analyses were performed by using CellQuest (Becton Dickinson, Mountain View, CA, USA) and Flowjo software (Treestar, San Carlos, CA, USA).
Sample processing and chip hybridization Splenocytes stored in RNAlater were pelleted at 5000 rpm for 5 min. RNA was extracted using an RNeasy Mini Kit with on-column DNase digestion (Qiagen Inc., Valencia, CA, USA). cDNA synthesis was performed as described in the Expression Analysis Technical Manual (Affymetrix, Santa Clara, CA, USA). cRNA was synthesized with BioArray High-Yield Transcript Labeling kit (Enzo, New York, NY, USA). Then, 15 mg of labeled cRNA was chemically fragmented at 941C for 35 min. Affymetrix MG U74Av2 (Affymetrix, Santa Clara, CA, USA) oligonucleotide GeneChips were then probed, hybridized, stained, washed and scanned according to the manufacturer's protocol at the University of Minnesota Biomedical Genomics Center facility. Each spleen was processed independently as true biological replicates. There were 3-4 replicates at each time point.
Data processing
After scanning the array, GD Expressionist v4.0 software (GeneData Inc., Waltham, MA) was used to generate relative expression values for each gene with default settings and a scaling factor of 1500 to control for minor differences in hybridization intensities. Expression signal analysis was performed using Microsoft EXCEL. Hierarchical clustering analysis were performed using CLUSTER and visualized in TREEVIEW. 59 Significant gene clusters were initially filtered via dChip software v1.3. 60 See supplementary materials for additional details of data analysis.
Kidney pathology
Kidneys were fixed in 4% buffered formalin, embedded in paraffin, and then sectioned before staining with hematoxylin and eosin. Slides were scored for pathologic changes in a blinded fashion as described. 19 Briefly, slides were graded from 0 to 4 þ (0, none; 1 þ , mild; 2 þ , moderate; 3 þ , moderate-severe; 4 þ , severe) for each of the following categories: glomerular inflammation, proliferation, crescent formation, interstitial/tubular changes and necrosis. The final renal score was the sum of the individual scores, with crescent formation and necrosis weighted twice the values of the other variables.
